Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis
New England Journal of Medicine · 07.03.2024 · 390 (10) · 911-921
DOI: 10.1056/nejmoa2311155 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 07.03.2024. Verfasst von Michael E Wechsler und 16 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Medicine, National Jewish Health, Denver (M.E.W.); McMaster University and St. Joseph's Healthcare, Hamilton, ON, Canada (P.N.…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Churg-Strauss Syndrome, Anti-Inflammatory Agents, Interleukin-5 Receptor alpha Subunit. Die Arbeit wurde bisher 251-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: AstraZeneca.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Medicine, National Jewish Health, Denver (M.E.W.); McMaster University and St. Joseph's Healthcare, Hamilton, ON, Canada (P.N.); the Department of Internal Medicine, National Referral Center for R…
ORCID-Profile: David R W Jayne, David J Jackson
Förderung
- AstraZeneca
Zitieren
APA
Wechsler, M. E., Nair, P., Terrier, B., Walz, B., Bourdin, A., Jayne, D. R. W., Jackson, D. J., Roufosse, F., Börjesson Sjö, L., Fan, Y., Jison, M., McCrae, C., Necander, S., Shavit, A., Walton, C., Merkel, P. A., & MANDARA Study Group (2024). Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis. New England Journal of Medicine, 390(10), 911-921. https://doi.org/10.1056/nejmoa2311155
Vancouver
Wechsler ME, Nair P, Terrier B, Walz B, Bourdin A, Jayne DRW, et al. Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis. New England Journal of Medicine. 2024;390(10):911-921. doi:10.1056/nejmoa2311155
BibTeX
@article{Wechsler2024,
author = {Wechsler, Michael E and Nair, Parameswaran and Terrier, Benjamin and Walz, Bastian and Bourdin, Arnaud and Jayne, David R W and Jackson, David J and Roufosse, Florence and Börjesson Sjö, Lena and Fan, Ying and Jison, Maria and McCrae, Christopher and Necander, Sofia and Shavit, Anat and Walton, Claire and Merkel, Peter A and MANDARA Study Group, MANDARA Study Group},
title = {Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis},
journal = {New England Journal of Medicine},
year = {2024},
volume = {390},
number = {10},
pages = {911--921},
doi = {10.1056/nejmoa2311155}
}
EUVIMED